Other
UT-242
An intravenous formulation intended for post-event radiation-response applications.
Other
usil-therapeutics.com- Milestones0
- Sources1
- Operators—
- Components—
Other · No licensed photo on file
An intravenous formulation intended for post-event radiation-response applications.
Timeline
No milestones recorded for UT-242 yet. The timeline fills in as unveilings, tests, contracts and deliveries are sourced.
Sources1
- 1.
USIL Therapeutics · Supports: System
“UT-242: IV Infusion POST-EVENT RADIATION COUNTERMEASURE UT-242 is an intravenous formulation intended for use in hospitals, field clinics, and specialized treatment centers. It provides extended whole-body radiomitigation across major organ systems and is designed to support prolonged therapeutic coverage following radiation exposure.”
Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.